115 results
8-K
EX-99.1
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its lead asset NPM-115 … of once-yearly administration.
Moving forward, Vivani will focus on developing NPM-115 and its emerging pipeline of innovative miniature, long-term drug
8-K
EX-99.2
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
, long - term, drug implants to treat chronic diseases. Our NanoPortal ™ platform technology enables the design of implants aimed at improving medication … provide an attractive alternative to life - long injections or pills for long - term maintenance of GLP - 1 therapy for weight management 6 - Month
8-K
EX-99.1
5kvlki
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
8dv79yiqrd2lw5x4uws
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
57hlvxp azey
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
njuyt99yb8cv 2ky
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
ixtdx4tsm9798 sg
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
yba2fp0t6j7d
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
ak34 5nc27pw4xct
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
8rc5x27x64 7if4t
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
fulrxx7t
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.2
qw9o fvhj31a
15 May 23
Results of Operations and Financial Condition
6:49am
8-K
EX-99.1
6mvv 1whv0
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
y9fy0gfrb5 0sxfxcp
1 May 23
Revised proxy
4:49pm